The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease.

Stacy Desine,Brittany M. Hollister,Khadijah E. Abdallah,Anitra Persaud,Sara Chandros Hull,Vence L. Bonham

The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease.

2020

Stacy Desine
Brittany M. Hollister
Khadijah E. Abdallah
Anitra Persaud
Sara Chandros Hull
Vence L. Bonham

A first therapeutic target of somatic genome editing (SGE) is sickle cell disease (SCD), the most commonly inherited blood disorders, affecting more than 100,000 individuals in the United States. A...

Keywords:

Somatic cell
Genome editing
CRISPR
Blood Disorder
Bioinformatics
Disease
Cell
Informed consent
Clinical trial
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations